Search results
Mar 18, 2022 · Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year. Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 ...
Albert Bourla. October 21, 1961) is an American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer .
Mar 18, 2022 · Pfizer CEO Albert Bourla, Ph.D., is set to nab more than $24 million this year under a compensation package approved last month. (Pfizer) Pfizer has already made tens of billions of dollars in...
Apr 16, 2024 · The estimated Net Worth of Albert Bourla is at least $34.9 Million dollars as of 23 February 2024. Albert Bourla owns over 127,674 units of Pfizer stock worth over $11,433,448 and over the last 10 years he sold PFE stock worth over $5,557,386. In addition, he makes $17,929,000 as Chairman of the Board and Chief Executive Officer at Pfizer.
Apr 28, 2021 · First, after training as a veterinarian, he joined the company's animal-health unit in Greece in 1993. He then relocated to New York in 2001. And in 2010, he began to help lead the pharma business ...
Feb 12, 2022 · Bourla’s success as CEO helped human health and paid off on Wall Street. When he took over, the company generated $41.2 billion in revenue. By 2021, that number doubled, reaching $81.3 billion ...
Dec 14, 2020 · CEO Albert Bourla had his total compensation listed at almost $18 million. For each executive, about 50% or more of total reported compensation was paid in equity. Visit Business Insider's ...
Related searches
